Literature DB >> 23993949

Pharmacological strategy for overcoming opioid-induced ventilatory disturbances.

Satoko Kimura1, Akira Haji2.   

Abstract

Opioids are among the most frequently used analgesics for treatment of severe pain. However, certain of their side-effects, particularly ventilatory disturbances, often restrict their use. Separation of analgesia from respiratory depression has long been a goal in the basic research and therapeutic use of opioids. This report briefly describes opioid-induced respiratory depression and possible pharmacological strategies to counteract this without affecting analgesia.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholinesterase inhibitor; Methylxanthine; Opioid; Phosphodiesterase inhibitor; Respiratory depression; Serotonergic agonist

Mesh:

Substances:

Year:  2013        PMID: 23993949     DOI: 10.1016/j.ejphar.2013.08.007

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  The balance between effective opioid-based pain management and patient safety: can it be achieved?

Authors:  Michael D Reed
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

Review 2.  Neuronal mechanisms underlying opioid-induced respiratory depression: our current understanding.

Authors:  Jan-Marino Ramirez; Nicholas J Burgraff; Aguan D Wei; Nathan A Baertsch; Adrienn G Varga; Helen A Baghdoyan; Ralph Lydic; Kendall F Morris; Donald C Bolser; Erica S Levitt
Journal:  J Neurophysiol       Date:  2021-04-07       Impact factor: 2.714

3.  Hypoxia following etorphine administration in goats (Capra hircus) results more from pulmonary hypertension than from hypoventilation.

Authors:  Leith Carl Rodney Meyer; Robyn Sheila Hetem; Duncan Mitchell; Andrea Fuller
Journal:  BMC Vet Res       Date:  2015-02-03       Impact factor: 2.741

4.  The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.

Authors:  Wei Dai; Xiang Gao; Dian Xiao; Yu-Lei Li; Xin-Bo Zhou; Zheng Yong; Rui-Bin Su
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

5.  The latest pharmacologic ventilator.

Authors:  Joseph F Cotten
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.